Bank of New York Mellon
MYOV

Bank of New York Mellon’s Myovant Sciences Ltd. MYOV Stock Holding History

Bank of New York Mellon’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-57,415
Closed -$1.55M – 4467
2022
Q4 		$1.55M Buy
57,415
+31,294
+120% +$823K ﹤0.01% 2983
2022
Q3 		$469K Sell
26,121
-155
-0.6% -$2.48K ﹤0.01% 3598
2022
Q2 		$327K Sell
26,276
-307
-1% -$3.39K ﹤0.01% 3832
2022
Q1 		$354K Hold
26,583
– – ﹤0.01% 3916
2021
Q4 		$414K Hold
26,583
– – ﹤0.01% 3914
2021
Q3 		$597K Buy
26,583
+4,800
+22% +$105K ﹤0.01% 3709
2021
Q2 		$496K Sell
21,783
-19,342
-47% -$407K ﹤0.01% 3776
2021
Q1 		$846K Buy
41,125
+17,031
+71% +$388K ﹤0.01% 3428
2020
Q4 		$665K Buy
24,094
+615
+3% +$12K ﹤0.01% 3472
2020
Q3 		$330K Sell
23,479
-6,561
-22% -$122K ﹤0.01% 3686
2020
Q2 		$619K Sell
30,040
-1
-0% -$14 ﹤0.01% 3368
2020
Q1 		$227K Buy
30,041
+1
+0% +$11 ﹤0.01% 3703
2019
Q4 		$466K Sell
30,040
-397,517
-93% -$4.01M ﹤0.01% 3626
2019
Q3 		$2.22M Buy
427,557
+18,050
+4% +$134K ﹤0.01% 2699
2019
Q2 		$3.71M Sell
409,507
-7,056
-2% -$105K ﹤0.01% 2483
2019
Q1 		$9.94M Buy
416,563
+47,243
+13% +$966K ﹤0.01% 1976
2018
Q4 		$6.06M Buy
369,320
+357,454
+3,012% +$7.05M ﹤0.01% 2182
2018
Q3 		$315K Hold
11,866
– – ﹤0.01% 3814
2018
Q2 		$271K Hold
11,866
– – ﹤0.01% 3853
2018
Q1 		$252K Sell
11,866
-820
-6% -$12.5K ﹤0.01% 3850
2017
Q4 		$160K Buy
12,686
+820
+7% +$11K ﹤0.01% 3996
2017
Q3 		$184K Hold
11,866
– – ﹤0.01% 3892
2017
Q2 		$139K Sell
11,866
-11,918
-50% -$148K ﹤0.01% 3967
2017
Q1 		$279K Buy
23,784
+6,330
+36% +$72.6K ﹤0.01% 3771
2016
Q4 		$217K Buy
+17,454
New +$202K ﹤0.01% 3878

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of New York Mellon's MYOV Position: Q1 2023 in Review

Bank of New York Mellon sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 57,415 shares — an estimated $1.55M sold.

Bank of New York Mellon first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $9.94M in Q1 2019. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Bank of New York Mellon reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 57,415 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.55M.
  • Bank of New York Mellon first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
  • Bank of New York Mellon's Myovant Sciences Ltd. position peaked at $9.94M in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.